Prof. Xiaoying Li
Zhongshan Hospital, Fudan University, China
Reason: In recognition of his exceptional contributions to advancing our understanding of the complex interplay between non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes through his pioneering discoveries in molecular mechanisms of NAFLD, the linkage between NAFLD and type 2 diabetes, and epigenetic insights into diabetes transmission. His outstanding leadership, groundbreaking research, and unwavering dedication to mentorship have profoundly influenced the field of diabetes research in Asia and beyond.

Prof. Huijie Zhang
Nanfang Hospital, Southern Medical University, China
Reason: In recognition of outstanding contributions to diabetes, obesity, and nonalcoholic fatty liver disease research. His innovative clinical trials have unveiled new strategies for effective weight management, while his molecular studies have identified key pathways, such as the 17-hydroxyprogesterone / glucocorticoid receptor axis in diabetes-related hyperglycemia.

Prof. Chih-Yuan Wang
National Taiwan University Hospital, College of Medicine, National Taiwan University, Taiwan
Reason: In recognition of his exceptional contributions to diabetes and endocrinology through pioneering research, education, and visionary leadership. He conducted the first-ever statistical prevalence study of nonalcoholic fatty pancreas disease, a globally recognized milestone in the field. His unwavering commitment to innovation and mentorship continues to inspire excellence and shape the future of epidemiological study to improve diabetes care in Asia.